PodurI C D, Khanna A, Khundmiri S J, Khaja M N, Kumar K S, Sugunan V S, Habibullah C M, Das M R
Rajiv Gandhi Center for Biotechnology, Trivandrum, Kerala, India.
Acta Virol. 2001 Feb;45(1):1-6.
The antibody profile to various proteins of hepatitis C virus (HCV) was studied in 113 patients positive for HCV RNA in various disease statuses of hepatitis C (HC). A single peptide (E2/NS1, aa 413-436 of HCV polyprotein) chosen from a conserved region at the C-terminus of the hypervariable region (HVR) HVR1 of HCV was found to be sufficient for reliable diagnosis of the infection, even in the acute phase. Six hundred and one suspected HC cases and 200 voluntary blood donors were tested by this peptide. The sensitivity of detection of HCV antibodies by this peptide did not increase with addition of peptides from other HCV proteins. Our results clearly demonstrate that antibodies to HCV envelope proteins occur in a higher percentage of the infected population than those to other proteins. This emphasizes the necessity of using representative sequences from HCV envelope proteins in diagnostic immunoassays of this viral infection.
在113例处于丙型肝炎(HC)各种疾病状态且HCV RNA呈阳性的患者中,研究了针对丙型肝炎病毒(HCV)各种蛋白质的抗体谱。从HCV高变区(HVR)HVR1 C端保守区选择的单个肽段(E2/NS1,HCV多聚蛋白的第413 - 436位氨基酸)被发现足以可靠诊断感染,即使在急性期也是如此。用该肽段检测了601例疑似HC病例和200名自愿献血者。添加来自其他HCV蛋白的肽段后,该肽段检测HCV抗体的敏感性并未增加。我们的结果清楚地表明,与针对其他蛋白的抗体相比,感染人群中针对HCV包膜蛋白的抗体出现的百分比更高。这强调了在这种病毒感染的诊断免疫测定中使用HCV包膜蛋白代表性序列的必要性。